A new documentary titled 'The Ozempic Effect' has surged in popularity on Netflix, despite a wave of critical reviews from viewers. The film, which explores the use of GLP-1 drugs for weight management and their impact on society's perception of body image, originally premiered in 2025 but became available on Netflix UK recently. The documentary is a concise 51 minutes long, and features expert interviews and personal narratives from users of these weight-loss medications, examining their implications both personally and socioeconomically.

Produced by Paul Kemp, who is recognized for his previous work in the sports documentary sector, 'The Ozempic Effect' seeks to address the broader implications of GLP-1 drugs as they enter mainstream usage. With the increasing popularity of such drugs among individuals seeking weight loss solutions, the documentary sheds light on both the potential benefits and criticisms surrounding their use. Viewers have shared mixed feelings, reflecting a societal divide on the acceptance and understanding of medical interventions for weight management.

Despite its controversial reception, the documentary's rise in viewership on Netflix indicates a voyeuristic curiosity in contemporary health trends and the changing dynamics of body image. As discussions around the use of such medications continue, the film contributes to an ongoing dialogue about health, wellness, and societal expectations, leaving audiences to grapple with the multifaceted nature of personal and societal health choices.